<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd"><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="3.0" xml:lang="en" article-type="research article"><front><journal-meta><journal-id journal-id-type="publisher-id">OJOph</journal-id><journal-title-group><journal-title>Open Journal of Ophthalmology</journal-title></journal-title-group><issn pub-type="epub">2165-7408</issn><publisher><publisher-name>Scientific Research Publishing</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.4236/ojoph.2023.132023</article-id><article-id pub-id-type="publisher-id">OJOph-124995</article-id><article-categories><subj-group subj-group-type="heading"><subject>Articles</subject></subj-group><subj-group subj-group-type="Discipline-v2"><subject>Medicine&amp;Healthcare</subject></subj-group></article-categories><title-group><article-title>
 
 
  Self-Medication during Eye Affections among Consultant Patients at Chu-Iota
 
</article-title></title-group><contrib-group><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Assiatou</surname><given-names>Simaga</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Mohamed</surname><given-names>Kolé Sidibé</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="corresp" rid="cor1"><sup>*</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Nana</surname><given-names>Wangara</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Seydou</surname><given-names>Diallo</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Ibrahima</surname><given-names>Conaré</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Founè</surname><given-names>Keïta</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Adama</surname><given-names>Dembélé</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Nouhoum</surname><given-names>Guirou</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Seydou</surname><given-names>Bakayoko</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib></contrib-group><aff id="aff1"><addr-line>Institute of Ophthalmology and Tropical Africa (IOTA), Bamako, Mali</addr-line></aff><pub-date pub-type="epub"><day>09</day><month>05</month><year>2023</year></pub-date><volume>13</volume><issue>02</issue><fpage>256</fpage><lpage>262</lpage><history><date date-type="received"><day>15,</day>	<month>March</month>	<year>2023</year></date><date date-type="rev-recd"><day>16,</day>	<month>May</month>	<year>2023</year>	</date><date date-type="accepted"><day>19,</day>	<month>May</month>	<year>2023</year></date></history><permissions><copyright-statement>&#169; Copyright  2014 by authors and Scientific Research Publishing Inc. </copyright-statement><copyright-year>2014</copyright-year><license><license-p>This work is licensed under the Creative Commons Attribution International License (CC BY). http://creativecommons.org/licenses/by/4.0/</license-p></license></permissions><abstract><p>
 
 
  Introduction: According to the World Health Organization (WHO), self-medication consists in the fact that an individual resorts to a drug, on his own initiative or that of a loved one, with the aim of treating an ailment or a symptom that he identified himself without having recourse to a health professional. Self-medication involves the use of medicinal products by the consumer to treat self-recognized disorders or symptoms, or the intermittent or continued use of a medication prescribed by a physician for chronic or recurring diseases or symptoms. The aim of this study is to determine the different characteristics of ophthalmic self-medication at the CHU-IOTA. 
  Patients and Method: We conducted a prospective study in patients of any age who resorted to ophthalmological self-medication before the first consultation or during the ophthalmological care of consulting patients at the CHU-IOTA between January 1 and July 31, 2021. 
  Results: Over the period, 521 cases of ophthalmological self-medication were collected out of a total of 24,512 consultations, which corresponds to a frequency of 2.12%. The average age was 37.7 years, [2 months - 78]. The sex ratio was 0.50. Economic factors were the main factor mentioned, 66.79%. Corticosteroids accounted for 45.26% of the pharmacological class with dexamethasone/neomycin eye drops being the most widely used, 
  <em>i.e.</em> 22.94%. The most common complication was corticosteroid-induced ocular hypertension on ametropia, 
  <em>i.e.</em> 15.54%. Our patients were 68.13% educated. Among his educated patients 53.35% had no knowledge of the products. 
  Conclusion: Given the harm associated with this practice, awareness and information campaigns aimed at the population, caregivers and pharmacists or pharmacy vendors are necessary in order to reduce the frequency of the practice of self-medication.
 
</p></abstract><kwd-group><kwd>Self-Medication</kwd><kwd> Conditions</kwd><kwd> Eye</kwd><kwd> CHU-IOTA</kwd></kwd-group></article-meta></front><body><sec id="s1"><title>1. Introduction</title><p>According to the World Health Organization (WHO), self-medication consists in the fact that an individual resorts to a drug, on his own initiative or that of a loved one, with the aim of treating an ailment or a symptom that he himself identified without having recourse to a health professional [<xref ref-type="bibr" rid="scirp.124995-ref1">1</xref>] . Several factors can contribute to the growth and spread of self-medication, including economic, cultural, difficult access to health services [<xref ref-type="bibr" rid="scirp.124995-ref2">2</xref>] [<xref ref-type="bibr" rid="scirp.124995-ref3">3</xref>] . Ignorance, misunderstanding of the dangers of self-medication and simplification of their disease are among the factors of ophthalmic self-medication [<xref ref-type="bibr" rid="scirp.124995-ref4">4</xref>] [<xref ref-type="bibr" rid="scirp.124995-ref5">5</xref>] . Obtaining and consuming one or more medications without the advice of the eye care professional can have serious consequences [<xref ref-type="bibr" rid="scirp.124995-ref6">6</xref>] [<xref ref-type="bibr" rid="scirp.124995-ref7">7</xref>] . The prevalence of self-medication has risen sharply around the world. Common practice in developing countries, 80% of drugs purchased without a prescription in the world come from these countries [<xref ref-type="bibr" rid="scirp.124995-ref4">4</xref>] [<xref ref-type="bibr" rid="scirp.124995-ref8">8</xref>] . Globally, it varies from 25.6% to 73.6% [<xref ref-type="bibr" rid="scirp.124995-ref8">8</xref>] [<xref ref-type="bibr" rid="scirp.124995-ref9">9</xref>] . Very few studies have been conducted, hence the interest of this preliminary study at the CHU-IOTA in order to determine the extent of ophthalmological self-medication.</p></sec><sec id="s2"><title>2. Results</title><p>Over the period, 521 cases of ophthalmological self-medication were collected out of a total of 24,512 consultations, i.e. a frequency of 2.12%. There was a female predominance of 66.41% in the study population; the sex ratio (M/F) 175/346 was 0.50. The 21 - 40 age group was the most represented at 51.24%. The average age was 37.7 years, [2 months - 78]. Nearly half of our patients were in the informal sector, i.e. 47.79% and 68.13% were educated (read and understand instructions in French). Economic factors were the main factor mentioned, 66.79% (<xref ref-type="table" rid="table1">Table 1</xref>). They predominated in both sexes, i.e. 48.57% in males and 76.01% in females. These factors were also mentioned most often in the informal and formal sector, i.e. 86% and 49.03%. Allergic and bacterial conjunctivitis were the most encountered pathologies during ophthalmological self-medication, i.e. 20.53% and 17.85% of cases. Eye drops were the galenic form used at 79.32%. Corticosteroids represented 45.26% of the pharmacological class (<xref ref-type="table" rid="table2">Table 2</xref>). Dexamethasone/Neomycin eye drops were the most used, i.e. 22.94%. Corticosteroid-induced ocular hypertension on ametropia was the most common complication, 15.54% (<xref ref-type="table" rid="table3">Table 3</xref>). Patients practicing both self-medication and those</p><table-wrap id="table1" ><label><xref ref-type="table" rid="table1">Table 1</xref></label><caption><title> Distribution of patients according to factors motivating self-medication</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Factors motivating self-medication</th><th align="center" valign="middle" >Numbers</th><th align="center" valign="middle" >Percentages</th></tr></thead><tr><td align="center" valign="middle" >Economic factors</td><td align="center" valign="middle" >348</td><td align="center" valign="middle" >66.79</td></tr><tr><td align="center" valign="middle" >Cultural factors</td><td align="center" valign="middle" >20</td><td align="center" valign="middle" >3.83</td></tr><tr><td align="center" valign="middle" >Difficult access to health service</td><td align="center" valign="middle" >105</td><td align="center" valign="middle" >20.15</td></tr><tr><td align="center" valign="middle" >Others</td><td align="center" valign="middle" >48</td><td align="center" valign="middle" >9.23</td></tr><tr><td align="center" valign="middle" >Total</td><td align="center" valign="middle" >521</td><td align="center" valign="middle" >100.00</td></tr></tbody></table></table-wrap><p>prescribed by an eye health professional represented 19.57% of cases and 84.06% of patients said they had no knowledge of the products. The majority of the molecules were obtained via the pharmacy, i.e. 58.12%. The initiative came most often from the pharmacy in 50.86% of cases and 58.15% of cases said they were not satisfied. Among the patients with no knowledge of the products, 53.35%</p><table-wrap id="table2" ><label><xref ref-type="table" rid="table2">Table 2</xref></label><caption><title> Distribution of patients according to pharmacological class</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Therapeutic class</th><th align="center" valign="middle" >Number</th><th align="center" valign="middle" >Percentage</th></tr></thead><tr><td align="center" valign="middle" >Antibiotics</td><td align="center" valign="middle" >165</td><td align="center" valign="middle" >16.97</td></tr><tr><td align="center" valign="middle" >Antiallergic</td><td align="center" valign="middle" >229</td><td align="center" valign="middle" >23.55</td></tr><tr><td align="center" valign="middle" >Corticosteroids</td><td align="center" valign="middle" >440</td><td align="center" valign="middle" >45.26</td></tr><tr><td align="center" valign="middle" >NSAIDs</td><td align="center" valign="middle" >65</td><td align="center" valign="middle" >6.68</td></tr><tr><td align="center" valign="middle" >Hypotonizing</td><td align="center" valign="middle" >8</td><td align="center" valign="middle" >0.82</td></tr><tr><td align="center" valign="middle" >Tear substitute</td><td align="center" valign="middle" >29</td><td align="center" valign="middle" >2.98</td></tr><tr><td align="center" valign="middle" >Antiseptics</td><td align="center" valign="middle" >36</td><td align="center" valign="middle" >3.74</td></tr><tr><td align="center" valign="middle" >Total</td><td align="center" valign="middle" >972</td><td align="center" valign="middle" >100.00</td></tr></tbody></table></table-wrap><table-wrap id="table3" ><label><xref ref-type="table" rid="table3">Table 3</xref></label><caption><title> Distribution of patients according to complications encountered following self-medication</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Complications encountered</th><th align="center" valign="middle" >Number</th><th align="center" valign="middle" >%</th></tr></thead><tr><td align="center" valign="middle" >Corticosteroid-induced ocular hypertension + ametropia</td><td align="center" valign="middle" >23</td><td align="center" valign="middle" >15.54</td></tr><tr><td align="center" valign="middle" >Steroid-induced cataract + sequelae of ETCL</td><td align="center" valign="middle" ></td><td align="center" valign="middle" >14.86</td></tr><tr><td align="center" valign="middle" >Corticosteroid-induced cataract + allergic conjunctivitis</td><td align="center" valign="middle" >9</td><td align="center" valign="middle" >6.08</td></tr><tr><td align="center" valign="middle" >Corticosteroid-induced HTO + allergic conjunctivitis</td><td align="center" valign="middle" >50</td><td align="center" valign="middle" >33.73</td></tr><tr><td align="center" valign="middle" >Steroid-induced HTO + secondary glaucoma</td><td align="center" valign="middle" >12</td><td align="center" valign="middle" >8.10</td></tr><tr><td align="center" valign="middle" >Steroid-induced cataract + ametropia</td><td align="center" valign="middle" >30</td><td align="center" valign="middle" >20.27</td></tr><tr><td align="center" valign="middle" >Others</td><td align="center" valign="middle" >2</td><td align="center" valign="middle" >1.35</td></tr><tr><td align="center" valign="middle" >Total</td><td align="center" valign="middle" >148</td><td align="center" valign="middle" >100.00</td></tr></tbody></table></table-wrap><table-wrap id="table4" ><label><xref ref-type="table" rid="table4">Table 4</xref></label><caption><title> Distribution of patients according to factors motivating self-medication and profession</title></caption><table><tbody><thead><tr><th align="center" valign="middle"  rowspan="2"  >Factors motivating self-medication</th><th align="center" valign="middle"  colspan="5"  >Profession</th><th align="center" valign="middle"  rowspan="2"  >Total</th><th align="center" valign="middle"  rowspan="2"  >P</th></tr></thead><tr><td align="center" valign="middle" >Pupils/Students</td><td align="center" valign="middle" >Formal sectors</td><td align="center" valign="middle" >Informal sector</td><td align="center" valign="middle" >Children</td><td align="center" valign="middle" >Retired</td></tr><tr><td align="center" valign="middle" >Economic factors</td><td align="center" valign="middle" >40</td><td align="center" valign="middle" >51</td><td align="center" valign="middle" >214</td><td align="center" valign="middle" >17</td><td align="center" valign="middle" >26</td><td align="center" valign="middle" >348</td><td align="center" valign="middle" >P = 10<sup>−8</sup></td></tr><tr><td align="center" valign="middle" >Cultural factors</td><td align="center" valign="middle" >4</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >10</td><td align="center" valign="middle" >5</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >20</td><td align="center" valign="middle" >P = 0.037</td></tr><tr><td align="center" valign="middle" >Difficult access to health services</td><td align="center" valign="middle" >18</td><td align="center" valign="middle" >32</td><td align="center" valign="middle" >20</td><td align="center" valign="middle" >22</td><td align="center" valign="middle" >13</td><td align="center" valign="middle" >105</td><td align="center" valign="middle" >P = 10<sup>−8</sup></td></tr><tr><td align="center" valign="middle" >Others</td><td align="center" valign="middle" >18</td><td align="center" valign="middle" >20</td><td align="center" valign="middle" >5</td><td align="center" valign="middle" >3</td><td align="center" valign="middle" >2</td><td align="center" valign="middle" >48</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Total</td><td align="center" valign="middle" >80</td><td align="center" valign="middle" >104</td><td align="center" valign="middle" >249</td><td align="center" valign="middle" >47</td><td align="center" valign="middle" >41</td><td align="center" valign="middle" >521</td><td align="center" valign="middle" ></td></tr></tbody></table></table-wrap><p>Test statistique: P (&lt;0.05).</p><p>were educated. Economic factors were most often mentioned in patients who are in the informal and formal sector, respectively 86% and 49.03% (<xref ref-type="table" rid="table4">Table 4</xref>).</p></sec><sec id="s3"><title>3. Discussion</title><p>The frequency of ophthalmological self-medication in our study, 2.12%, is lower than those of Gabriel E et al. which was 25.6% of Noopur G. et al. which was 18.2% [<xref ref-type="bibr" rid="scirp.124995-ref2">2</xref>] - [<xref ref-type="bibr" rid="scirp.124995-ref10">10</xref>] . This difference can be explained by the large quantity of our sample compared to the studies cited above. Self-medication occurs at any age [<xref ref-type="bibr" rid="scirp.124995-ref11">11</xref>] . And the practice does not depend on gender [<xref ref-type="bibr" rid="scirp.124995-ref12">12</xref>] . The female predominance in our sample could be explained by the fact that we interviewed more women than men during the survey. The majority of our patients, 47.79% of whom were in the informal sector and 19.96% in the formal sector. This could be due to the fact that the majority of subjects in the formal sector having a stable economic level and being most often insured in health insurance tend to take care of their state of health by consulting in the different health structures [<xref ref-type="bibr" rid="scirp.124995-ref13">13</xref>] [<xref ref-type="bibr" rid="scirp.124995-ref14">14</xref>] .</p><p>Self-medication does not depend on the level of school attendance [<xref ref-type="bibr" rid="scirp.124995-ref15">15</xref>] . According to our results 68.13% of patients were educated. In several jurisdictions economic factors have long been associated with self-medication [<xref ref-type="bibr" rid="scirp.124995-ref4">4</xref>] . Concerning our study, economic factors were the most mentioned, i.e. 66.79%, followed by difficult access to health services, i.e. 20.15%. Our results are in agreement with the studies carried out in Ghana [<xref ref-type="bibr" rid="scirp.124995-ref5">5</xref>] . But parallel to those of Angeline S et al. among whom the availability of drugs in pharmacies (easy accessibility) was the most mentioned, i.e. 30.4%; only 11.7% cited economic reasons (high cost of products) [<xref ref-type="bibr" rid="scirp.124995-ref16">16</xref>] . In the study conducted by Thomas B et al., 76.8% of cases mentioned economic factors, in particular the high cost of drugs [<xref ref-type="bibr" rid="scirp.124995-ref8">8</xref>] . Thus our results and those of certain authors indicate that socio-economic status is likely to be involved in this habit of self-medication [<xref ref-type="bibr" rid="scirp.124995-ref2">2</xref>] [<xref ref-type="bibr" rid="scirp.124995-ref4">4</xref>] [<xref ref-type="bibr" rid="scirp.124995-ref16">16</xref>] . The use of ophthalmological drugs without the advice of a professional can lead to serious ophthalmological complications. Thus we found 15.54% of complications all induced by corticosteroid therapy. Eye drops are considered mild or harmless, hence their misuse [<xref ref-type="bibr" rid="scirp.124995-ref11">11</xref>] . Corticosteroids were the most common pharmacological class, i.e. 45.26%. The desire for rapid relief is the most likely factor in the strong presence of corticosteroid therapy. And Dexamethasone/Neomycin was the most encountered in our sample, i.e. 22.94% followed by Olopatadine i.e. 19.75% Framycetin sulphate/Dexamethasone phosphate 7.81% indomethacin 6.68% gentamycin i.e. 6.06%. Pharmacists and their assistants play an important role in promoting self-medication all over the world [<xref ref-type="bibr" rid="scirp.124995-ref5">5</xref>] - [<xref ref-type="bibr" rid="scirp.124995-ref10">10</xref>] . In our sample, the initiative came from the pharmacy at 50.86%, relatives at 32.82% and the patient himself at 16.32%. by pharmacists decreases the practice of self-medication [<xref ref-type="bibr" rid="scirp.124995-ref5">5</xref>] . The majority of the molecule was obtained via the pharmacy at 58.12% and by the family at 19.3% and 19.57% used both prescribed drugs by an eye health professional and those recommended by pharmacists. More than half of the patients, 84.06%, had no knowledge of the products before self-medication and 58.15% declared that they were not satisfied with the practice.</p><p>When a person becomes ill, they may want to self-medicate first without seeking professional medical care [<xref ref-type="bibr" rid="scirp.124995-ref11">11</xref>] [<xref ref-type="bibr" rid="scirp.124995-ref17">17</xref>] . The reasons for this practice are varied. There are several contributing factors. Regarding our study, economic factors were the most mentioned, i.e. 66.79%, followed by difficult access to health services, i.e. 20.15%. Our results are in agreement with studies carried out in Ghana [<xref ref-type="bibr" rid="scirp.124995-ref5">5</xref>] . But parallel to those of Angeline S et al. among whom the availability of drugs in pharmacies (easy accessibility) was the most mentioned, i.e. 30.4%; only 11.7% cited economic reasons (high cost of products) [<xref ref-type="bibr" rid="scirp.124995-ref15">15</xref>] . For Kara-Jos&#233; the difficulties in obtaining medical care were the major reason for this practice [<xref ref-type="bibr" rid="scirp.124995-ref11">11</xref>] . In several jurisdictions economic factors have long been associated with self-medication [<xref ref-type="bibr" rid="scirp.124995-ref4">4</xref>] . Hence, in the study conducted by Thomas B et al, 76.8% of cases mentioned economic factors, in particular the high cost of drugs [<xref ref-type="bibr" rid="scirp.124995-ref8">8</xref>] . A.L. Gramajo et al. and S. Kyei et al. also mentioned the low economic level as the main factor of this practice [<xref ref-type="bibr" rid="scirp.124995-ref5">5</xref>] [<xref ref-type="bibr" rid="scirp.124995-ref6">6</xref>] . Thus our results and those of certain authors imply that socio-economic status is likely to be involved in this habit of self-medication [<xref ref-type="bibr" rid="scirp.124995-ref2">2</xref>] [<xref ref-type="bibr" rid="scirp.124995-ref4">4</xref>] [<xref ref-type="bibr" rid="scirp.124995-ref16">16</xref>] . For patients with a high socio-economic level, longer waiting times in health establishments, lack of confidence in medical services were the factors mentioned, as in previous studies [<xref ref-type="bibr" rid="scirp.124995-ref2">2</xref>] .</p></sec><sec id="s4"><title>4. Conclusion</title><p>Self-medication is a common practice in developing countries. Economic factors were the most often mentioned and pharmacies were the main access point for medications for this practice of ocular self-medication. Corticosteroids were the most common for self-medication in conjunctivitis. This poses a real risk on the one hand for the complications related to these drugs and on the other hand, the socio-economic impact generated by this practice.</p></sec><sec id="s5"><title>Limitations of the Study</title><p>The limits of our study were the duration of the study, the difficulty of collecting information on the questionnaire due to the absence of a pretext.</p></sec><sec id="s6"><title>Conflicts of Interest</title><p>The authors declare no conflicts of interest regarding the publication of this paper.</p></sec><sec id="s7"><title>Cite this paper</title><p>Simaga, A., Sidib&#233;, M.K., Wangara, N., Diallo, S., Conar&#233;, I., Ke&#239;ta, F., Demb&#233;l&#233;, A., Guirou, N. and Bakayoko, S. (2023) Self-Medication during Eye Affections among Consultant Patients at Chu-Iota. Open Journal of Ophthalmology, 13, 256-262. https://doi.org/10.4236/ojoph.2023.132023</p></sec><sec id="s8"><title>Survey</title>A. Sociodemographic Data<p>File number…………Patient code …………………</p><p>1-Age:………ans</p><p>2-Sex: ………. (1) F (2) M</p><p>3-Origin:……… (1) Bamako (2) Region (3) Outside Mali</p><p>4-Marital status: …….. (1) Married (2) Widowed (3) Divorced(e) (4) Single</p><p>5-Level of school attendance: …… (1) primary, uneducated</p><p>(2) secondary; (3) superior.</p><p>6-Profession:……… (1) Pupil-Student (2) formal sector (3) informal sector</p>B. Interrogation<p>7-Previous treatment: ………….. Yes</p><p>8-Self-medication: ………..Yes</p><p>9-Type of medicine used:…………… (1) Eye drops (2) ointments (3) gels (4) tablets</p><p>10-Name of molecule(s) used:………………………………</p><p>11-Therapeutic class:………</p><p>(1) antibiotics, (2) antiallergics, (3) corticosteroids,</p><p>(4) nonsteroidal anti-inflammatory drugs (NSAIDs),</p><p>(5) vasoconstrictors, (6) saline solution (7) other substances…… ….</p><p>12-Knowledge of the product(s):…………………………..</p><p>13-Circumstances in which the product was obtained:……</p><p>(1) Pharmacy (2) A friend (3) Neighbor</p><p>(4) Family (5) Prescription abuse (6) other…………….</p><p>14-Clinical signs before self-medication:…………………………</p><p>15-Clinical signs during self-medication:……………….</p><p>16-The results obtained:………….</p><p>(1) satisfaction (2) lack of result</p><p>(3) worsening of symptoms (4) other…………………………..</p><p>17-Diagnosis retained:………………………………</p>C. Factors Motivating Self-Medication<p>18-Economic factors:……………………………………………….</p><p>19-Cultural factors:…………………………. ……………………….</p><p>20-Access to health services:……………………………………..</p><p>21-Others:……………………………………………………………</p></sec></body><back><ref-list><title>References</title><ref id="scirp.124995-ref1"><label>1</label><mixed-citation publication-type="other" xlink:type="simple">World Heath Organisation (WHO) (2000) Guidelines for the Regulatory Assess ment of Medicinal Products for Use in Self-Medication: 9.</mixed-citation></ref><ref id="scirp.124995-ref2"><label>2</label><mixed-citation publication-type="other" xlink:type="simple">Shankar, P.R., Partha, P. and Shenoy, N. (2002) Self-Medication and Nondoctor Prescription Practices in Pokhara Valley, Western Nepal: A Questionnaire Based Study. BMC Family Practice, 3, Article No. 17. https://doi.org/10.1186/1471-2296-3-17</mixed-citation></ref><ref id="scirp.124995-ref3"><label>3</label><mixed-citation publication-type="other" xlink:type="simple">Chang, F.R. and Trivedi, P.K. (2003) Economics of Self-Medication: Theory and Evidence. Health Economics, 12, 721-739. https://doi.org/10.1002/hec.841</mixed-citation></ref><ref id="scirp.124995-ref4"><label>4</label><mixed-citation publication-type="other" xlink:type="simple">Ajayi, I.A., Omotoye, O.J., Ajite, K.O., Fadamiro, C.O. and Ajayi, E.A. (2014) Self Medication Practices among Patients Seen in a Suburban Tertiary Eye Care Centre in Nigeria. Asian Journal of Medical Sciences, 5, 85-90. https://doi.org/10.3126/ajms.v5i2.8452</mixed-citation></ref><ref id="scirp.124995-ref5"><label>5</label><mixed-citation publication-type="other" xlink:type="simple">Kyei, S., Ocansey, S., Abu, E.K. and Gyedu, B.N. (2014) Appraisal of the Practice of Ocular Self-Medication in Cape Coast Metropolis, Ghana. Optometry Reports, 4, 2164. https://doi.org/10.4081/optometry.2014.2164</mixed-citation></ref><ref id="scirp.124995-ref6"><label>6</label><mixed-citation publication-type="other" xlink:type="simple">Carvalho, R.S., Kara-José, N., Temporini, E.R., Kara-Junior, N. and Noma-Campos, R. (2009) Self-Medication: Initial Treatments Used by Patients Seen in an Ophthalmologic Emergency Room. Clinics, 64, 735-741. https://doi.org/10.1590/S1807-59322009000800005</mixed-citation></ref><ref id="scirp.124995-ref7"><label>7</label><mixed-citation publication-type="other" xlink:type="simple">Limaye, D., Limaye, V., Krause, G. and Fortwengel, G. (2017) A Systematic Review of the Literature on Survey Questionnaires to Assess Self-Medication Practices. International Journal of Community Medicine and Public Health, 4, 2620-2631. https://doi.org/10.18203/2394-6040.ijcmph20173192</mixed-citation></ref><ref id="scirp.124995-ref8"><label>8</label><mixed-citation publication-type="other" xlink:type="simple">Bisika, T., Courtright, P., Geneau, R., Kasote, A., Chimombo, L. and Chirambo, M. (2010) Self Treatment of Eye Diseases in Malawi. African Journal of Traditional, Complementary and Alternative Medicines, 6, 23-29. https://doi.org/10.4314/ajtcam.v6i1.57070</mixed-citation></ref><ref id="scirp.124995-ref9"><label>9</label><mixed-citation publication-type="other" xlink:type="simple">World Health Organization (WHO) (2008) Guidelines for the Regulatory Assessment of Medicinal Products for Use in Self-Medication. WHO, Geneva.</mixed-citation></ref><ref id="scirp.124995-ref10"><label>10</label><mixed-citation publication-type="other" xlink:type="simple">Gupta, N., Vashist, P., Tandon, R., Gupta, S.K., Kalaivani, M. and Dwivedi, S.N. (2017) Use of Traditional Eye Medicine and Self-Medication in Rural India: A Population-Based Study. PLOS ONE, 12, e0183461. https://doi.org/10.1371/journal.pone.0183461</mixed-citation></ref><ref id="scirp.124995-ref11"><label>11</label><mixed-citation publication-type="other" xlink:type="simple">Marquez, G.E., Torres, V.E., Sanchez, V.M., et al. (2012) Self-Medication in Ophthalmology: A Questionnaire-Based Study in an Argentinean Population. Ophthalmic Epidemiology, 19, 236-241. https://doi.org/10.3109/09286586.2012.689076</mixed-citation></ref><ref id="scirp.124995-ref12"><label>12</label><mixed-citation publication-type="other" xlink:type="simple">Abasaeed, A., Vlcek, J., Abuelkhair, M. and Kubena, A. (2009) Self-Medication with Antibiotics by the Community of Abu Dhabi Emirate, United Arab Emirates. The Journal of Infection in Developing Countries, 3, 491-497. https://doi.org/10.3855/jidc.466</mixed-citation></ref><ref id="scirp.124995-ref13"><label>13</label><mixed-citation publication-type="other" xlink:type="simple">Adimassu, N.F., Woldetsadik, Z.G. and Alemu, H.W. (2020) Proportion of Ophthalmic Self-Medication and Associated Factors among Adult Ophthalmic Patients Attending Borumeda Hospital, Dessie, Northeast Ethiopia. Journal of Ophthalmology, 2020, Article ID: 6932686. https://doi.org/10.1155/2020/6932686</mixed-citation></ref><ref id="scirp.124995-ref14"><label>14</label><mixed-citation publication-type="other" xlink:type="simple">Calamusa, A., Marzio, A., Cristofani, R., et al. (2012) Factors That Influence Italian Consumers’ Understanding of Over-the-Counter Medicines and Risk Perception. Patient Education and Counseling, 87, 395-401. https://doi.org/10.1016/j.pec.2011.10.003</mixed-citation></ref><ref id="scirp.124995-ref15"><label>15</label><mixed-citation publication-type="other" xlink:type="simple">Shallam, A. and Mendonca, N. (2017) Self-Medication Practices among Patients Attending Ophthalmology Opd in a Tertiary Hospital in Mangalore. IOSR Journal of Dental and Medical Sciences (IOSR-JDMS), 16, 11-13. https://www.iosrjournals.org</mixed-citation></ref><ref id="scirp.124995-ref16"><label>16</label><mixed-citation publication-type="other" xlink:type="simple">Tayanithi, P. and Aramwit, P. (2005) Self-Medicated over the Counter Ophthalmic Solutions in Central Bangkok. Journal of the Medical Association of Thailand, 88, S330-S334.</mixed-citation></ref><ref id="scirp.124995-ref17"><label>17</label><mixed-citation publication-type="other" xlink:type="simple">Pagan, J.A., Ross, S., Yau, J. and Polsky, D. (2006) Self-Medication and Health Insurance Coverage in Mexico. Health Policy, 75, 170-177. https://doi.org/10.1016/j.healthpol.2005.03.007</mixed-citation></ref></ref-list></back></article>